Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia |
University of California San Francisco / Mignon Loh, M.D. |
Innovation Grants |
2014 |
California |
A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer |
University of California San Francisco / Tina Baggott, RN, PhD, PNP |
Nurse Researcher Grants |
2009 |
California |
Blockade of Mycn in neuroblastoma
|
University of California San Francisco / William Weiss |
Innovation Grants |
2008 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Integrative Genomic and Immunogenomic Analysis of Neuroblastoma |
University of California at Santa Cruz / David Haussler, PhD |
Innovation Grants |
2015 |
California |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
Targeted Degradation of Proliferative Transcription Factors in Pediatric Cancers |
University of California at Santa Cruz / Seth Rubin, PhD |
Innovation Grants |
2017 |
California |
Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma |
University of California San Francisco / Ozlem Aksoy, PhD |
Young Investigator Grants |
2015 |
California |
Saving Lives, Saving Neurons, the Head Start Consortium for Young Children with Malignant Central Nervous System Tumors
|
Children’s Hospital Los Angeles / Jonathan Finlay, MD |
Phase I/II Infrastructure Grants |
2007 |
California |
New Approaches to Neuroblastoma Therapy (NANT) Consortium
|
Children’s Hospital Los Angeles / Robert Seeger, MD |
Phase I/II Infrastructure Grants |
2006 |
California |